While more research is needed, obesity does play a role in the response to viral infections as well as immunizations, said Kara Dupuy-McCauley, MD, a pulmonologist at the Mayo Clinic in Rochester, Minnesota.
Obesity, which is widespread in the United States, impacts the response to viral infections as well as immune response to vaccines, said Kara Dupuy-McCauley, MD, a pulmonologist at the Mayo Clinic in Rochester, Minnesota, who spoke at CHEST 2022.
Transcript
What is the impact of obesity on viral infections and immunizations?
Well, to summarize the impact of obesity on viral infections and immunizations, I think that we do probably need to do a little bit more work to understand exactly what the impacts are, especially when it comes to obesity and immunizations, because I think that body of literature has a little bit more contradictory information. But I think that it's safe to say that obesity does increase the risk of contracting a viral infection, at least in the specific viral infections where it has been studied. And, it's widely known that obesity also increased the risk of morbidity and mortality as a result of viral infection.
And I think, based on the research that I've done, there probably is a difference in in vaccine response just because of the immunity impairment that comes along with obesity. But I think we do need a little bit more research to understand exactly what the impact is.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More